Evidence map›Paper›PMID 29315834›Full record

ReviewSeminars in dialysis2018

Medical safety in the care of the person with end-stage kidney disease.

John V Duronville, Clarissa J Diamantidis

Abstract readReview
In one paragraph

Review in Seminars in dialysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John V DuronvilleDivision of Nephrology, Duke University School of Medicine, Durham, NC, USA.
Clarissa J DiamantidisDivision of Nephrology, Duke University School of Medicine, Durham, NC, USA.

Funding

Multi-factorial Intervention to Slow Progression of Diabetic Kidney DiseaseR01DK093938 · NIDDK · DUKE UNIVERSITY · PI BOSWORTH, HAYDEN B, DIAMANTIDIS, CLARISSA JONAS · 2013 to 2017
$3.4M
Is there a digital divide in Chronic Kidney Disease (CKD)?K23DK099385 · NIDDK · DUKE UNIVERSITY · PI DIAMANTIDIS, CLARISSA JONAS · 2014 to 2017
$678k
NIDDK NIH HHS K23 DK099385NIDDK NIH HHS R01 DK093938
6 · The paper itself

Abstract

Much is written about medical safety as it pertains to patients with chronic kidney disease, yet the transition to end-stage kidney disease and processes inherent to the receipt of dialysis present unique safety challenges in this population. Educational efforts in medical safety need to focus on the areas of greatest threat and where intervention can provide the greatest benefit. This study addresses such safety topics in the dialysis population and identifies potential strategies that may aid in harm reduction.

Indexed as

Patient SafetyAdministration, OralAnalgesicsAnti-Bacterial AgentsAnticoagulantsDrug Therapy, CombinationFemaleHemodialysis Units, HospitalHumansKidney Failure, ChronicMalePatient Care TeamRenal DialysisSafety ManagementAnalgesicsAnti-Bacterial AgentsAnticoagulants

Identifiers

PMID29315834
PMCPMC5839985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.